ArticleNature biotechnology2022
The characteristics of patents impacting availability of biosimilars.
Article in Nature biotechnology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed.
- Consideration of the biosimilar drug lag and loss among Japan, the USA, and the EU.Naunyn-Schmiedeberg's archives of pharmacology · 2026Article
- Frequency of first generic drugs approved through "skinny labeling," 2021 to 2023.Journal of managed care & specialty pharmacy · 2025Article
- The puzzle of biologics manufacturing platform patents.Nature biotechnology · 2025Article
- The Golden Card of Interleukin-1 Blockers in Systemic Inflammasomopathies of Childhood.International journal of molecular sciences · 2025Review
- Biologic patent challenges under the America Invents Act.Nature biotechnology · 2024Article
- The prevalence of drug patent term extensions in the United States, 2000-2018.Nature biotechnology · 2023Article
- Frequency of Approval and Marketing of Biosimilars With a Skinny Label and Associated Medicare Savings.JAMA internal medicine · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
35043019What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.